Lunit: A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint...

Read the latest publication from RareCyte. Journal of Clinical Oncology: Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)1 ICI therapy Understanding the mechanisms of acquired resistance...

The application, known as iStar, was created by Perelman School of Medicine researchers to give clinicians more insights into gene activities in medical images and, potentially, help them diagnose cancers that might have otherwise been...

Read how Orion™ was used to identify improved prognostic signatures for colorectal cancer patients in this publication from Harvard Medical School. "High-plex immunofluorescence imaging and traditional histology of the same tissue section...

PreciseDx study analyzes more than 2,000 patient samples, confirming the technology delivers more accurate, objective, diagnostic data than traditional testing.  January 23, 2023 —  PreciseDx, a leading innovator in AI-powered,...

aetherAI has designed an AI-assisted lymph node assessment workflow and revealed the improvement of micrometastasis identification sensitivity from 81% to 95%. TAIPEI, TAIWAN, September 15, 2022 /EINPresswire.com/ -- aetherAI—Asia’s...